BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25824098)

  • 1. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
    Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
    J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.
    Pasquali D; Circelli L; Faggiano A; Pancione M; Renzullo A; Elisei R; Romei C; Accardo G; Coppola VR; De Palma M; Ferolla P; Grimaldi F; Colao A; Colantuoni V
    Eur J Endocrinol; 2011 Mar; 164(3):397-404. PubMed ID: 21177330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
    Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study.
    Shyamasunder AH; Pai R; Ramamoorthy H; Sakhti D; Manipadam MT; Kapoor N; Paul TV; Jebasingh F; Thomas N; Abraham DT; Paul MJ; Chacko AG; Prabhu K; Rajaratnam S
    Horm Metab Res; 2021 Apr; 53(4):245-256. PubMed ID: 33853118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia, the old and the new: a mini review.
    Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G
    G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
    Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
    Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
    Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.
    Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G
    Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
    Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
    Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
    Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
    Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
    Lindberg D; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27kip1: a new multiple endocrine neoplasia gene?
    Marinoni I; Pellegata NS
    Neuroendocrinology; 2011; 93(1):19-28. PubMed ID: 20980721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
    Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.